MEDI-522

A substance being studied in the treatment of some types of cancer and other conditions. MEDI-522 binds to a protein on the surface of blood vessels and may prevent the growth of new blood vessels that tumors need to grow. It may also prevent the spread of cancer. It is a type of antiangiogenesis agent, a type of metastasis inhibitor, and a type of monoclonal antibody. Also called Abegrin, etaracizumab, and humanized monoclonal antibody MEDI-522. (NCI Dictionary)

YOU MAY ALSO LIKE

MEDI-507

A monoclonal antibody that is being studied in the treatment of certain lymphoproliferative disorders and psoriasis. Also called siplizumab.

Meddra System Organ Class

Highest level of the Meddra terminology, and distinguished by anatomical or physiological system, etiology, or purpose.

Meddra Low Level Term

Lowest level of the Meddra terminology, related to a single PT as a synonym, lexical variant, or quasi-synonym.

Meddra High Level Term

A superordinate descriptor for one or more Meddra preferred terms (PTs). It is subordinate to high level group term (HLGT).

Meddra High Level Group Term

A superordinate descriptor for one or more Meddra high level terms (HLT). It is subordinate to System Organ Class (SOC).

MedDRA

An international medical terminology designed to support the classification, retrieval, presentation, and communication of medical information throughout the medical product regulatory…